Crestovo Investor LLC 13D and 13G filings for Finch Therapeutics Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-01 5:22 pm Purchase |
2021-03-23 | 13D | Finch Therapeutics Group, Inc. FNCH |
Crestovo Investor LLC | 421,381 26.800% |
421,381 (New Position) |
Filing |